NASDAQ
3.52USD
0.00 (0.00%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
8.7M
P/E
—
EPS
—
Beta
-1.46
52W range
2.485-97.5
Day range
2.72–3.79
Open
2.72
Prev close
3.52
Volume
536.3K
Avg volume
563.9K
Dividend
0.00
IPO
2025-02-25
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/wellgistics-health-appoints-brett-thompson-as-chief-technology-office-1191323 · 7/15/2026+0.60
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/wellgistics-health-executive-chairman-and-president-exercise-warrants-1184501 · 6/30/2026+0.60
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/wellgistics-health-provides-mid-year-2026-corporate-outlook-1172128 · 6/1/2026+0.60
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/wellgistics-health-announces-lock-up-agreement-with-holders-of-a-majo-1171384 · 5/28/2026+0.60
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/wellgistics-health-refinances-outstanding-convertible-debt-and-raises-1171274 · 5/27/2026
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/wellgistics-health-announces-launch-of-diabetes-drug-brenzavvyr-to-we-1115365 · 12/8/2025+1.00
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/wellgistics-health-nasdaq-wgrx-and-theracosbio-partner-to-expand-nati-1079815 · 9/30/2025+0.80
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/wellgistics-health-inc.-to-present-at-september-investor-conferences-1069151 · 9/5/2025+0.20
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/wellgistics-health-achieves-stability-in-first-half-2025-and-executes-1063183 · 8/20/2025+0.80
https://www.accessnewswire.com/newsroom/en/blockchain-and-cryptocurrency/wellgistics-health-nasdaq-wgrx-launches-xrp-payment-program-for-indep-1060334 · 8/13/2025+0.80
Wellgistics Health, Inc. functions as a primary wholesaler and distributor of pharmaceutical products throughout the United States, catering to both drug manufacturers and independent retail pharmacies. Its extensive product catalog includes a variety of generic and brand-name pharmaceuticals, alongside over-the-counter healthcare and consumer merchandise. The company also delivers a suite of third-party logistics (3PL) services, encompassing warehousing, inventory control, pick-and-pack operations, and shipping solutions, specifically designed for small to mid-sized pharmaceutical producers. Furthermore, Wellgistics manages the DelivMeds platform, an integrated pharmaceutical hub that streamlines prescription transfers and offers essential backend clinical concierge support to its network of independent pharmacies. It also runs a specialized retail community service. Established in 2022 and headquartered in Tampa, Florida, the organization adopted its current name, Wellgistics Health, Inc., in October 2024, having previously operated as Danam Health, Inc.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works